Merck spends $10 billion for Verona, gaining access to its COPD medication

3 months ago 132
Pharmaceutical elephantine Merck is buying Verona Pharma, a institution that focuses connected respiratory diseases, successful an astir $10 cardinal deal.
Read Entire Article
  1. Homepage
  2. Health
  3. Merck spends $10 billion for Verona, gaining access to its COPD medication

Related

Former student sues University of Southern Mississippi and Omega Psi Phi over alleged hazing

Former student sues University of Southern Mississippi and O...

2 weeks ago 28
10 Pushing Exercises to Light Up Your Shoulders, Chest, and Triceps

10 Pushing Exercises to Light Up Your Shoulders, Chest, and ...

2 weeks ago 29
Tylenol maker rebounds a day after Trump's unfounded claims about its safety

Tylenol maker rebounds a day after Trump's unfounded claims ...

2 weeks ago 27
Darfur cholera cases rising at an 'alarming' rate as death toll in Sudan tops 3,000, says WHO

Darfur cholera cases rising at an 'alarming' rate as death t...

2 weeks ago 26
FDA announces plan for folinic acid to be accessible prescription treatment for children with autism

FDA announces plan for folinic acid to be accessible prescri...

2 weeks ago 28
Trump links autism to Tylenol, sparking backlash from maker and medical groups

Trump links autism to Tylenol, sparking backlash from maker ...

2 weeks ago 28

Trending


English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Global Insight: Exploring Finance, Sports, Crypto, Travel, and More at BookFinder.tn 2025. All rights are reserved